Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-006110
Filing Date
2020-07-02
Accepted
2020-07-02 16:39:08
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-49167.html 4  
1 PRIMARY DOCUMENT marketforms-49167.xml 4 3941
  Complete submission text file 0001214659-20-006110.txt   5444
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address
Hernday Natasha (Reporting) CIK: 0001780547 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 201010048